Contracts › 36C26126F0008
36C26126F0008: Lutathera Cancer Therapy
Awarded to Novartis Pharmaceuticals Corporation by Department of Veterans Affairs.
$1.3Mobligated
$3.4Mpotential value
30 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 36C26126F0008 |
|---|---|
| Vehicle | 36F79720D0180 |
| Awardee | Novartis Pharmaceuticals Corporation |
| Awarding agency | Department of Veterans Affairs |
| Awarding office | 261-NETWORK CONTRACT OFFICE 21 (36C261) |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | NJ |
| Offers received | 1 |
| Period of performance | 01 October 2025 to 30 September 2027 |
| Potential end | 30 September 2030 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 09 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record